Amniotic fluid characteristics and its application in stem cell therapy: A review
Open Access
- 6 September 2022
- journal article
- review article
- Published by Knowledge E DMCC in International Journal of Reproductive BioMedicine (IJRM)
- Vol. 20 (8) , 627-643
Abstract
Amniotic fluid (AF) is a clear yellow fluid that surrounds the fetus during pregnancy. The amniotic sac consists of 2 layers: the amnion and the chorion. Osmotic and hydrostatic forces cause the maternal plasma to pass through the fetal skin and generate the AF. AF allows the fetus to grow inside the uterus, supports it from injuries, retains consistent pressure and temperature, and enables the exchange of body chemicals with the mother. At first, it consists of water and electrolytes but after the 12-14th wk the liquid also contains carbohydrates, proteins, lipids, phospholipids, urea, hormones, and some biochemical products. AF appearance is characterized by the grade of cloudiness and the number of flakes of the vernix. The volume of AF increases with the fetus’s growth. Its appearance depends on the gestational age. In addition to differentiated cells, stem cells are also found within the AF. These cells express embryonic-specific cell markers and bear high self-renewal capacity and telomerase activity. AF stem cells possess the potential to differentiate into osteogenic, cardiac, skeletal muscle, lung, neuronal, kidney, bone, cartilage, ovarian and hepatic cells in vitro. They represent a great promise in regenerative medicine for the reconstruction of bio-artificial tissues and organs in vivo. The purpose of this paper was to briefly review the development and function of AF and the application of its stem cells in cell therapy. Key words: Amniotic fluid, Stem cells, Differentiation, Regeneration, Tissue engineering.Keywords
This publication has 102 references indexed in Scilit:
- Human amniotic fluid-derived and dental pulp-derived stem cells seeded into collagen scaffold repair critical-size bone defects promoting vascularizationStem Cell Research & Therapy, 2013
- Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free ApproachMolecular Therapy, 2012
- Amniotic-Fluid–Derived Mesenchymal Stem Cells Overexpressing Interleukin-1 Receptor Antagonist Improve Fulminant Hepatic FailurePLOS ONE, 2012
- Activation of Regulatory T Cells during Inflammatory Response Is Not an Exclusive Property of Stem CellsPLOS ONE, 2012
- Enhanced generation of retinal progenitor cells from human retinal pigment epithelial cells induced by amniotic fluidBMC Research Notes, 2012
- Cell sourcing for bone tissue engineering: Amniotic fluid stem cells have a delayed, robust differentiation compared to mesenchymal stem cellsStem Cell Research, 2011
- Isolation and Characterization of Porcine Amniotic Fluid-Derived Multipotent Stem CellsPLOS ONE, 2011
- Hepatic differentiation of amniotic epithelial cellsHepatology, 2011
- Human Amniotic Fluid as a Potential New Source of Organ Specific Precursor Cells for Future Regenerative Medicine ApplicationsJournal of Urology, 2010
- Isolation of amniotic stem cell lines with potential for therapyNature Biotechnology, 2007